|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.11 CAD||-0.01 (-4.55%)||0.04 - 0.57||103.0 thousand (Above Avg)|
Market data as of 10:45AM 07/31/15. Quotes are delayed by at least 15 min.
Antibe Therapeutics Reports Year-End Financial and Operating Results
Business Wire - Tuesday 07/28/2015 7:45 PM ET
Antibe Therapeutics Announces Addition of Aspirin Derivative to Its Product Pipeline and Provides an Update on Validation Studies
Business Wire - Monday 07/20/2015 1:30 PM ET
Antibe Therapeutics Announces Change in CFO Position and Granting of Employee Stock Options
Business Wire - Monday 07/13/2015 7:45 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.